AdaptHealth Corp. Announces Second Quarter 2024 Results

Go back to AdaptHealth Corp. Announces Second Quarter 2024 Results

UBS Reiterates Buy Rating on AdaptHealth (AHCO)

August 8, 2024 9:31 AM EDT

UBS analyst Kevin Caliendo reiterated a Buy rating and $13.00 price target on AdaptHealth (NASDAQ: AHCO).

The analyst comments "AHCO's fundamentals remain relatively stable, the company appears to be gaining some market share, and margins are holding steady. The CGM shift to pharmacy (now 20% of the market) has... More